EKF Diagnostics (LON:EKF) , the Point of Care in-vitro diagnostics company, announced that it has signed a distribution agreement with Diagnostica Peruana SAC in Peru. Under the agreement, Diagnostica Peruana will distrubute and provide customer support for EKF's Hemo-Control product. Hemo-Control is a Point of Care blood haemoglobin and hematocrit test instrument designed for use in doctors' offices. The Hemo-Control system is used to screen for illnesses such as diabetes and anaemia.

EKF also received a Hemo-Control order worth over €1 million from the Peruvian Ministry of Health (MINSA). The contract is for the purchase of 3,000 Hemo-Control devices along with an initial two month supply of consumable cuvettes (transparent tubes which hold blood test samples). The Company is currently tendering for the ongoing supply of cuvettes to MINSA, and because the Hemo-Control device requires EKF's proprietary cuvettes the company is confident that this effort will be successful. Recurring sales of consumables such as the cuvettes used in Hemo-Control tests are a key component of EKF's business model.

In other news, EKF’s board announced that CEO Julian Baines and Exec Chairman David Evans have been granted options on EKF Diagnostics Shares which amount to 6% each of the companies issued share capital.

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here